X0306 4 2021-01-06 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001373097 JONES WILLIAM A JR C/O BIOHAVEN PHARMACEUTICALS 215 CHURCH STREET NEW HAVEN CT 06510 false true false false CCO-Migraine & Common Disease Common Shares 2021-01-06 4 M false 5000.00 0.00 A 9251.00 D Common Shares 2021-01-06 4 F false 2124.00 83.38 D 7127.00 D Employee Stock Option (right to buy) 83.38 2021-01-06 4 A false 40000.00 0.00 A 2031-01-06 Common Shares 40000.00 40000.00 D Restricted Share Unit Award 2021-01-06 4 A false 20000.00 0.00 A Common Shares 20000.00 20000.00 D Restricted Share Unit Award 2021-01-06 4 M false 5000.00 0.00 D Common Shares 5000.00 15000.00 D This balance includes 741 shares that were acquired through the Biohaven Employee Share Purchase Plan on November 30, 2020. No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. The shares underlying this option vest in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service with the Issuer at each vesting date. Each restricted share unit represents the contingent right to receive one common share of the Issuer. The reporting person was granted 20,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date. Not applicable. /s/ Jim Engelhart, Attorney-in-Fact 2021-01-08